Helicopter Crash at Camp Pendleton Kills 2 Marines, Sparks Wildfire
September 21, 2011 | Read the story »

Central Florida Pharmaceutical Litigation Attorneys Discuss Recall of Digitek

2009-04-28 14:01:10 (GMT) (JusticeNewsFlash.com - Press Release, Product liability)



/rueziffra.com/Allan Ziffra-Pharmaceutical Litigation Attorney/ 04/24/2009
In April of 2008, the pharmaceutical company Actavis Totowa issued a nationwide recall of all lots of Digitek distributed by Mylan Pharmaceuticals due to the risk that these pills may contain a hazardous double-dose of the active ingredient digoxin. The Digitek recall was Class I in nature, meaning that the drug in question has the potential to cause death or serious health complications. The specific defect in the recalled lots of Digitek was that the tablets were manufactured at twice their intended size. Accordingly, these tablets contained double the approved level of digoxin which has led to dangerous overdoses in many consumers.

Digitek is designed to treat congestive heart failure and abnormal heart rhythms. However, when patients consume more than the prescribed amount of this drug, a condition known as digitalis toxicity can occur. This form of toxicity can be caused by consuming the recalled double-strength Digitek tablets. Symptoms of digitalis toxicity include:

  • Nausea
  • Vomiting
  • Abnormally low blood pressure
  • Cardiac instability & heart palpitations
  • Cold sweats
  • Dizziness
  • Irregular pulse/slow heart rate (bradycardia)
  • Trouble breathing, particularly when lying down
  • Loss of appetite
  • Loss of consciousness
  • Decreased urination
  • Visual changes in color perception, particularly yellow & green-like distortions
  • Death

Many Digitek consumers were notified of the recall by their pharmacies subsequent to the April 2008 news. If a family member has died due to heart/cardiac complications, find out if they were taking Digitek during the time period leading up to their death. If you or a loved one was prescribed a recalled lot of Digitek and suffered harm, contact the product liability and medical malpractice attorneys at Rue & Ziffra, P.A. Our law offices can be reached at 1-888-246-8613. Alternatively, visit Florida Product Liability Lawyers / Pharmaceutical Litigation Attorneys Rue & Ziffra website at www.RueZiffra.com for more information on the nationwide Digitek recall and the ways in which our legal team can help you achieve the compensation you deserve.

Press Release Contact Information:
Central Florida Pharmaceutical Litigation Attorney Rue & Ziffra
632 Dunlawton Ave,
Port Orange,
Florida 32127
Toll Free: 1-888-246-8613
Tags: Attorney, medical malpractice attorneys, pharmaceutical litigation, Product liability, Rue, Ziffra
Online Press Release Legal News Distribution - JusticeNewsFlash.com

Justicenewsflash.com is comprised of news and articles contributed by: West Palm Beach personal injury lawyers, Business litigation attorneys,  mesothelioma attorneys, construction accident attorneys, drug product liability lawyers, employment lawyers, medical malpractice lawyers, and family / divorce law specialists.

To submit news please review Justice News Flash -

Press Release Submission Guidelines.

Personal Injury Lawyer Directory

West Palm Beach Injury Lawyers
Dallas Injury Lawyers
New York City Injury Lawyers
New Jersey Injury Lawyers Chicago Injury Lawyers Boston Injury Law Firms

Bay Area Injury Lawyers

Torrance California serious injury

Raleigh Lawyers
North Carolina Law Firms
Daytona Beach Injury Lawyers Miami Law Firms


If you want to become a legal news contributor, please call our editorial contact

 

News Providers: American Injury News |   JusticeNewsFlash on Google News  |   New York Injury Lawyers News  |   Sitemap  |   Video News

Press Release Distribution | Lawyers, Law Firms | Attorneys | JusticeNewsFlash.com - News Service

Developed By: Vision Smart News